Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Clinical trial PREADVISE, investigating whether vitamin E and selenium can prevent Alzheimer’s disease, has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility [Phase 4]
Phase 4 trial evaluating the effectiveness and safety of donepezil hydrochloride (E2020) in adults with mild to severe Alzheimer's disease r…
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: Behavioral Expressions in Alzheimer's Disease
A University of Florida–sponsored clinical trial investigating behavioral expressions in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease [Phase 2]
Phase 2 pilot trial of Exendin-4 in Alzheimer's disease and mild cognitive impairment was terminated.
-
CLINICAL_TRIALS trial_result · 2018-02-20Clinical Trial Update: Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil [Phase 3]
A Phase 3 trial evaluating idalopirdine in patients with mild-to-moderate Alzheimer's disease already treated with donepezil has completed; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease [Phase 2]
Phase 2 trial evaluating ORM-12741 for agitation/aggression in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-12Clinical Trial Update: Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease [Phase 2]
Phase 2 study comparing SB-742457 or donepezil against placebo in mild-to-moderate Alzheimer's disease; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-12Clinical Trial Update: The Effect of rTMS Treatment on Alzheimer's and Sleep Quality [NA]
A completed clinical trial evaluating the effect of repetitive transcranial magnetic stimulation (rTMS) on Alzheimer's disease and sleep qua…
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor [Phase 3]
Phase 3 trial investigating idalopirdine in mild-to-moderate Alzheimer's disease patients already on acetylcholinesterase inhibitors; study …
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012) [Phase 2]
Phase 2 trial evaluating MK-7622 as adjunct therapy in Alzheimer's disease was terminated with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: Trial of Carvedilol in Alzheimer's Disease [Phase 4]
Phase 4 clinical trial of carvedilol in Alzheimer's disease has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: Alzheimer's Disease Acitretin Medication [Phase 2]
Phase 2 clinical trial of acitretin for Alzheimer disease completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-01Clinical Trial Update: Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120) [Phase 2]
Phase 2 study evaluating long-acting nasal insulin detemir for cognitive decline in Alzheimer’s disease and mild cognitive impairment has co…
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Venlafaxine for Depression in Alzheimer's Disease (DIADs-3) [NA]
Clinical trial update for venlafaxine in Alzheimer's disease with comorbid depression; study completed and results posted.
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease [Phase 2]
Phase 2 clinical trial of deep transcranial magnetic stimulation for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-24Clinical Trial Update: DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia [Phase 2]
Phase 2 clinical trial update for DAOIB addressing cognitive function and behavioral and psychological symptoms in dementia, completed.
-
CLINICAL_TRIALS trial_result · 2018-01-11Clinical Trial Update: Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET [Phase 2]
Phase 2 clinical trial evaluating practice effects and amyloid imaging using 18F-PIB or Flutemetamol PET and FDG-PET in Alzheimer's disease …
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD [NA]
Johns Hopkins University completed a clinical trial investigating disrupted sleep, neuroendocrine status, and behavioral symptoms in Alzheim…
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease [Phase 2]
A Phase 2 trial evaluated SB-742457 added to donepezil for mild-to-moderate Alzheimer's disease. The study is completed and results were pos…
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: LESCOD: "Lewy Body Screening in Cognitive Disorders" [NA]
The LESCOD study on Lewy body screening in cognitive disorders (NCT02263287) sponsored by Nantes University Hospital has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
A completed clinical study evaluated the kinetics of CNS and plasma amyloid-beta in people with Alzheimer's disease. The update reports biom…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Treatment for Aggression and Agitation in Patients With Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating a treatment for aggression and agitation in Alzheimer's disease by Eli Lilly has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease [NA]
A clinical trial evaluating rosiglitazone extended-release tablets as an adjunctive therapy for mild-to-moderate Alzheimer's disease has com…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia [Phase 1, Phase 2]
The document reports that Phase 1 and Phase 2 studies of ITI-007 (lumateperone) in healthy elderly volunteers and elderly patients with Alzh…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Retinal Neurodegenerative Signs in Alzheimer's Diseases [NA]
This document provides an update on a completed clinical trial evaluating retinal neurodegenerative signs in Alzheimer's disease.